These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12164379)

  • 21. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    Wu D; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to deliver peptide drugs to the brain.
    Lalatsa A; Schatzlein AG; Uchegbu IF
    Mol Pharm; 2014 Apr; 11(4):1081-93. PubMed ID: 24601686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.
    Alaofi A; On N; Kiptoo P; Williams TD; Miller DW; Siahaan TJ
    J Pharm Sci; 2016 Feb; 105(2):797-807. PubMed ID: 26869430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain drug targeting and gene technologies.
    Pardridge WM
    Jpn J Pharmacol; 2001 Oct; 87(2):97-103. PubMed ID: 11700018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC-MS/MS and Gd-DTPA Using Magnetic Resonance Imaging.
    Tabanor K; Lee P; Kiptoo P; Choi IY; Sherry EB; Eagle CS; Williams TD; Siahaan TJ
    Mol Pharm; 2016 Feb; 13(2):379-90. PubMed ID: 26705088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain and CSF specific chemical delivery systems for beta-lactam antibiotics. Study of two dihydropyridine derivatives of benzylpenicillin in rabbits and dogs.
    Wu WM; Pop E; Shek E; Clemmons R; Bodor N
    Drug Des Deliv; 1990 Dec; 7(1):33-43. PubMed ID: 2096832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
    Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
    Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery.
    Chai Z; Hu X; Wei X; Zhan C; Lu L; Jiang K; Su B; Ruan H; Ran D; Fang RH; Zhang L; Lu W
    J Control Release; 2017 Oct; 264():102-111. PubMed ID: 28842313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system.
    Prokai L; Zharikova AD
    Brain Res; 2002 Oct; 952(2):268-74. PubMed ID: 12376188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain.
    Son S; Hwang DW; Singha K; Jeong JH; Park TG; Lee DS; Kim WJ
    J Control Release; 2011 Oct; 155(1):18-25. PubMed ID: 20800628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.
    Sun T; Zhang Y; Power C; Alexander PM; Sutton JT; Aryal M; Vykhodtseva N; Miller EL; McDannold NJ
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10281-E10290. PubMed ID: 29133392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide sequences mediating tropism to intact blood-brain barrier: an in vivo biodistribution study using phage display.
    Smith MW; Al-Jayyoussi G; Gumbleton M
    Peptides; 2012 Nov; 38(1):172-80. PubMed ID: 22955033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain.
    Pardridge WM; Triguero D; Buciak JL
    Endocrinology; 1990 Feb; 126(2):977-84. PubMed ID: 2137082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier.
    Pardridge WM; Kumagai AK; Eisenberg JB
    Biochem Biophys Res Commun; 1987 Jul; 146(1):307-13. PubMed ID: 2955786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.
    Pardridge WM; Kang YS; Buciak JL
    Pharm Res; 1994 May; 11(5):738-46. PubMed ID: 8058646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient transduction of 11 poly-arginine peptide in an ischemic lesion of mouse brain.
    Gotanda Y; Wei FY; Harada H; Ohta K; Nakamura KI; Tomizawa K; Ushijima K
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2023-2030. PubMed ID: 25081308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs.
    Banks WA; Audus KL; Davis TP
    Peptides; 1992; 13(6):1289-94. PubMed ID: 1494505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.
    Gynther M; Ropponen J; Laine K; Leppänen J; Haapakoski P; Peura L; Järvinen T; Rautio J
    J Med Chem; 2009 May; 52(10):3348-53. PubMed ID: 19402664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.